RPMI-1788 SMAD/TGFbeta Reporter (Luc) stable cell line
Selected Variant
GTR15423870
Size: 1 Vial
RPMI-1788 SMAD/TGFbeta Reporter (Luc) cells are derived from the human B lymphocyte RPMI-1788 cell line by stably integration of a SMAD/TGFbeta firefly luciferase reporter construct. RPMI-1788 cells have been used in cancer research and drug development. RPMI-1788 SMAD/TGFbeta Reporter (Luc) cells stably express firefly luciferase under the control of the SMAD/TGFbeta response elements, can be used for monitoring the activity of TGF?/SMAD signaling pathway.
Product Specifications
No additional specifications available.
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog